Company page

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc. (ticker: XFOR) is a public company based in the United States, focusing on developing innovative therapies for rare diseases. With a market capitalization of approximately $360.3 million, X4 is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company operates within the pharmaceutical sector, emphasizing research and development in its strategic initiatives.